Periactin and Nexium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Periactin (cyproheptadine hydrochloride) and Nexium (esomeprazole magnesium). Common drug interactions include bronchitis among females and infective pulmonary exacerbation of cystic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Periactin and Nexium. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Periactin?

Periactin has active ingredients of cyproheptadine hydrochloride. It is often used in migraine. eHealthMe is studying from 2,214 Periactin users. Check the latest studies of Periactin.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,678 Nexium users. Check the latest studies of Nexium.



On Jul, 31, 2026

91 people who take Periactin and Nexium together, and have interactions are studied.

Periactin and Nexium drug interactions.

What are the common drug interactions of Periactin and Nexium, by gender? *:

female:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Death
  3. Nasal polyps (masses that develop in the lining of the nose)
  4. Nephropathy (damage to or disease of a kidney)
  5. Suicidal ideation
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Cellulitis (infection under the skin)
  9. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  10. Coagulopathy (blood's ability to clot is impaired)

male:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Staphylococcal infection (an infection with staphylococcus bacteria)
  3. Anaemia (lack of blood)
  4. Aspartate aminotransferase increased
  5. Asthenia (weakness)
  6. Fall
  7. Gamma-glutamyltransferase increased
  8. Hospitalisation
  9. Vomiting
  10. Gastric cancer (stomach cancer)

What are the common drug interactions of Periactin and Nexium, by age (0-1 to 60+)? *:

0-1:

  1. Abdominal compartment syndrome (increased pressure in abdomen)
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Blood lactic acid increased
  4. Cholecystitis (infection of gallbladder)
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Coagulopathy (blood's ability to clot is impaired)
  7. Duodenal perforation (complication of duodenal ulcer)
  8. Enterococcal infection
  9. Fluid retention (an abnormal accumulation of fluid in the blood)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

2-9:

  1. Staphylococcal infection (an infection with staphylococcus bacteria)
  2. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  3. Red man syndrome (a reaction to the drug vancomycin)
  4. Otitis media (inflammation of the middle ear)
  5. Alanine aminotransferase increased
  6. Aspartate aminotransferase increased
  7. Gamma-glutamyltransferase increased
  8. Hepatomegaly (abnormal enlargement of the liver)
  9. Chronic kidney disease
  10. Hepatic enzyme increased

10-19:

  1. Nasal polyps (masses that develop in the lining of the nose)
  2. Atelectasis (partial or complete collapse of the lung)
  3. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  4. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  5. Pneumonia
  6. Pyrexia (fever)
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Cystic fibrosis (disease of the secretary glands)
  9. Facial pain
  10. Metastases to central nervous system (cancer spreads to central nervous system)

20-29:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Allergy to animal
  3. Gastric fistula (abnormal opening that allows the contents of the stomach or intestines to leak)
  4. Nausea (feeling of having an urge to vomit)
  5. Vomiting
  6. Weight decreased

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Death
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Nephropathy (damage to or disease of a kidney)
  5. Renal failure (kidney dysfunction)
  6. Cholecystitis acute (rapid infection of gallbladder)
  7. Drug level increased
  8. Hypokalaemia (low potassium)
  9. Suicidal ideation

50-59:

  1. Blood thyroid stimulating hormone decreased
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Drug ineffective
  5. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  6. Metastases to adrenals (cancer spreads to adrenal gland of kidney)
  7. Metastases to lymph nodes (cancer spreads to lymph node)
  8. Oral candidiasis (fungal infection of mouth)
  9. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  10. Vaginal burning sensation

60+:

  1. Asthenia (weakness)
  2. Anaemia (lack of blood)
  3. Chest pain
  4. Chronic kidney disease
  5. Confusional state
  6. Constipation
  7. Dizziness
  8. Drug toxicity
  9. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  10. Head injury

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 21 people, 23.08%
  2. Pain: 16 people, 17.58%
  3. Depression: 10 people, 10.99%
  4. High Blood Pressure: 8 people, 8.79%
  5. Cough: 7 people, 7.69%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 6.59%
  7. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 5 people, 5.49%
  8. Restless Leg Syndrome (a powerful urge to move your legs): 5 people, 5.49%
  9. Joint Pain: 5 people, 5.49%
  10. Itching: 5 people, 5.49%

* Approximation only. Some reports may have incomplete information.

Do you take Periactin and Nexium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Periactin and Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Periactin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Periactin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nexium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cyproheptadine hydrochloride and esomeprazole magnesium (the active ingredients of Periactin and Nexium, respectively), and Periactin and Nexium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: